Facetten
Zugriff
Einrichtung
Medientyp
- Text 9
Karte
Erscheinungsjahr
Autor/in
- Munder, Markus
- Bertsch, Uta 6
- Mai, Elias K 6
- Weisel, Katja C 6
- Scheid, Christof 4
- alle zeigen
Sprache
- Englisch 9
9 Einträge gefunden
-
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma
- Mai, Elias K
- Huhn, Stefanie
- Miah, Kaya
- Poos, Alexandra M
- Scheid, Christof
- Weisel, Katja C
- Bertsch, Uta
-
Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy
- Chari, Ajai
- Munder, Markus
- Weisel, Katja
- Jenner, Matthew
- Bygrave, Ceri
- Petrucci, Maria Teresa
- Boccadoro, Mario
-
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
- Baertsch, Marc-Andrea
- Mai, Elias K
- Hielscher, Thomas
- Bertsch, Uta
- Salwender, Hans J
- Munder, Markus
- Fuhrmann, Stephan
-
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
Health-related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial
- Hungria, Vania
- Beksac, Meral
- Weisel, Katja C
- Nooka, Ajay K
- Masszi, Tamas
- Spicka, Ivan
- Munder, Markus
-
Selective elimination of immunosuppressive T cells in patients with multiple myeloma
- Awwad, Mohamed H S
- Mahmoud, Abdelrahman
- Bruns, Heiko
- Echchannaoui, Hakim
- Kriegsmann, Katharina
- Lutz, Raphael
- Raab, Marc S
-
Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial
- Klein, Eva-Maria
- Tichy, Diana
- Salwender, Hans J
- Mai, Elias K
- Duerig, Jan
- Weisel, Katja C
- Benner, Axel
-
-